The real costs of emesis

Eur J Cancer. 1993;29A(3):297-8. doi: 10.1016/0959-8049(93)90369-q.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiemetics / economics*
  • Antiemetics / therapeutic use
  • Carboplatin / adverse effects
  • Cisplatin / adverse effects
  • Drug Costs*
  • Female
  • Humans
  • Metoclopramide / therapeutic use
  • Ondansetron / therapeutic use
  • Ovarian Neoplasms / drug therapy

Substances

  • Antiemetics
  • Ondansetron
  • Carboplatin
  • Metoclopramide
  • Cisplatin